磷酸肌酸对早期舒张功能障碍的疗效

　　Our clinical observation had proved that intravenous therapy with CP can significantly increase clinical (96.2% vs. 57.1%),E/A (81.65% vs. 10.34%), Ea/Aa (83.49% vs. 13.79%) and E/Ea (92.86% vs. 12.00%) effects, P<0.01 all, compared with routine treatment group,therefore, a better life quality will provided to the patients. Thereby creatine phosphate sodium has invaluable clinical significance in preventing and treating myocardium diastolic dysfunction

　　【参考文献】

　　\[1\]　郭继鸿.舒张性心衰的新理念.北京：人民卫生出版社，2009：10.

　　[2]李佳蓓，黄岚，祝善俊. 心力衰竭时心肌能量代谢的研究进展. 心血管康复医学杂志, 2009, 18(1)：85.

　　[3]Hearse DJ, Stewart DA , Braimbridge MV,et al. Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic Circulation, Vol 54, 193-202.

　　[4]袁彪 朱朗标 王冬青,等.外源性磷酸肌酸在心脏直视术中心肌保护效果的观察.解放军医学杂志，2000，25(2)：112-114.

　　[5]Grazioli G， Melzi， Strumia E.Multicenter controlled study of creatine phosphate in the treatment of heart failure.Current Therapeutic Research,1992,52(2):271-280.

　　[6]Scattolin G，Gabellini A，Desideri A.Diastolic function and creatine phosphate : an echocardiographic study.Current therapeutic research,1993, vol. 54, 562-571.

　　[7]刘瑛琪， 李天德，任艺虹，等.磷酸肌酸对心肌细胞线粒体的保护作用.心脏杂志，2004， 16(1)：14-16.

　　[8]王琴.卡托普利对心脏病心衰患者心钠素的影响，新疆医学院学报，1996，1：24.

　　[9]吴蔚，高宁.磷酸肌酸治疗充血性心力衰竭的临床观察[J].心血管康复医学杂志，2000，9(4)：52-54.

　　[10]Ferraro S. Acute and short-term efficacy of high doses of creatine phosphate in the treatment of cardiac failure. Cum Therap. Research，1990, 47 (6): 917.

　　[11]Pedone V. As assessment of the activity of creatine phosphate (Neoton) on premature ventricular beats by continuous ECG monitoring in patients with coronary cardiac disease. Clinical Trials J，1984, 21：91.

上一页  [1] [2] [3] [4] [5] [6]